Axitinib

Axitinib is used to treat patients suffering from kidney cancer, when previous treatments to stop the disease have failed or are no longer working. Axitinib is a tyrosine kinase inhibitor, and works by blocking specific substances in the body that cause the growth and multiplication of cancer cells.

Do not use Axitinib if you are allergic to any of the ingredients present in Axitinib, or if you have a case of recent bleeding in the bowels of the stomach. Before using Axitinib tell your doctor if you are pregnant and/or breastfeeding, if you are using any prescription drugs, non-prescription drugs, or other herbal and dietary pills and supplements, if you are allergic to certain food items or substances, if you have thyroid or kidney or liver problems, if you have high blood pressure, if you have a history of stomach problems, if you have a history of heart diseases, or if you take medicines for high blood pressure.

Axitinib is administered in the form of oral tablets, which should be taken as prescribed by the doctor.

Common side effects of Axitinib include bleeding gums, stomach or abdominal pain, blurred vision, confusion, constipation, decreased urination, dry mouth and lightheadedness.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Kidney Cancer

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Headache

• Nausea

• Rash

• Breathing Difficulty

• Joint Pain

• Difficulty In Speaking

• Decreased Level Of Thyroid Hormones

• Pain In Extremity

• Haemorrhage

• Vomiting

• Abdominal Pain

• Dyspepsia

• Dry Skin

• Diarrhoea

• Increased Blood Pressure

• Decreased Appetite

• Cough

• Altered Taste

• Hand-Foot Syndrome

• Constipation

• Stomatitis (Inflammation Of The Mouth)

• Protein In Urine

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Is It safe with alcohol?

  Interaction with alcohol is unknown. Please consult your doctor.

• Are there any pregnancy warnings?

  Inlyta 5mg tablet is unsafe to use during pregnancy.
  There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.

• Are there any breast-feeding warnings?

  Inlyta 5mg tablet is probably unsafe to use during breastfeeding. Please consult your doctor.

• Is it safe to drive while on this medicine?

  Patients should be advised that they may experience events such as dizziness and/or fatigue during treatment with axitinib.

• Does this affect kidney function?

  There is no interaction between renal impairment and consuming this drug. So dose alteration is not needed.

• Does this affect liver function?

  There is no data available. Please consult doctor before consuming the drug.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

Below is the list of medicines, which contains Axitinib as ingredient

• Inlyta 5Mg Tablet

  Pfizer Ltd

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

This medicine is used in the treatment of advanced kidney cancer. It judiciously inhibits the tyrosine kinase receptors VEGFR-1, which is the vascular endothelial growth factor receptor, VEGFR-2, and VEGFR-3, thereby halting the multiplication of cancer.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.